This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Melacini P et al. (2007) Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart 93: 708–710
Ho CY and Seidman CE (2006) A contemporary approach to hypertrophic cardiomyopathy. Circulation 113: e858–e862
Ellenbogen KA et al. for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators (2006) Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113: 776–782
Acknowledgements
The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
A Kadish has acted as a Consultant for Impulse Dynamics and Lifewatch and has received research support from Medtronic and St Jude Medical.
Rights and permissions
About this article
Cite this article
Kadish, A. Can ICDs prevent sudden cardiac death effectively in patients with hypertrophic cardiomyopathy?. Nat Rev Cardiol 5, 76–77 (2008). https://doi.org/10.1038/ncpcardio1062
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio1062